Selvita Overview
- Founded
- 2007

- Status
- Public
- Employees
- 900

- Stock Symbol
- SLV

- Investments
- 3
- Share Price
- $17.50
- (As of Thursday Closing)
Selvita General Information
Description
Selvita SA is a Poland based company focused on the areas of drug discovery, regulatory studies, as well as research and development.
Contact Information
- Park Life Science
- Bobrzynskiego 14
- Krakow, 30-348
- Poland
Selvita Stock Performance
(As of Thursday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$17.50 | $17.38 | $13.16 - $22.32 | $321M | 18.4M | 11.8K | $0.21 |
Selvita Financials Summary
In Thousands, USD |
TTM 31-Dec-2021 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2018 31-Dec-2018 |
---|---|---|---|---|
EV | 391,217 | 391,217 | 228,576 | |
Revenue | 80,482 | 80,482 | 35,221 | 19,559 |
EBITDA | 13,549 | 13,549 | 8,461 | 4,479 |
Net Income | 3,857 | 3,857 | 4,615 | 2,905 |
Total Assets | 114,874 | 114,874 | 58,716 | 19,288 |
Total Debt | 44,266 | 44,266 | 11,071 | 2,014 |
Selvita Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Selvita‘s full profile, request access.
Request a free trialSelvita Comparisons
Industry
00000000
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialSelvita Competitors (9)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Sygnature Discovery | Private Equity-Backed | Nottingham, United Kingdom | 000 | 00000000000 | ||
00000000 | Venture Capital-Backed | San Carlos, CA | 00 | 00000 | 000000000000 | 00000 |
00000000 | Formerly VC-backed | San Diego, CA | 000 | 00000 | 000000&0 | 00000 |
00000 00000000000 | Formerly VC-backed | Hayward, CA | 000 | 00000 | 000000000 | 00000 |
000000 00000000000 | Venture Capital-Backed | Cambridge, MA | 00 | 00000 | 00000000000 | 00000 |
Selvita Patents
Selvita Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20180305331-A1 | Pyridone derivatives and their use as kinase inhibitors | Abandoned | 22-Oct-2015 | 0000000000 | |
AU-2016341259-A1 | Pyridone derivatives and their use as kinase inhibitors | Granted | 22-Oct-2015 | 0000000000 | |
AU-2016341259-B2 | Pyridone derivatives and their use as kinase inhibitors | Expired - Fee Related | 22-Oct-2015 | 0000000000 | 0 |
CA-3002875-A1 | Pyridone derivatives and their use as kinase inhibitors | Abandoned | 22-Oct-2015 | 0000000000 | |
JP-2018531266-A | Pyridone derivatives and their use as kinase inhibitors | Ceased | 22-Oct-2015 | C07D401/04 | 0 |
Selvita Executive Team (12)
Selvita Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
00000 0000000000000000 | Self | Board Member | 000 0000 |
Selvita Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialSelvita Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Selvita‘s full profile, request access.
Request a free trialSelvita Investments & Acquisitions (3)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000 | 04-Jan-2021 | 0000000000 | 000.00 | Drug Discovery | |
0000000000 | 21-Oct-2010 | 000000000 | Biotechnology | 00000ł00 | |
BioCentrum | 31-Mar-2008 | Merger/Acquisition | Biotechnology | 00000 000 |
Selvita Subsidiaries (2)
Company Name | Industry | Location | Founded |
---|---|---|---|
Fidelta | Drug Discovery | Zagreb, Croatia | 2013 |
0000000000 | Biotechnology | Krakow, Poland | 0000 |